Background: Metabolically healthy obesity (MHO) refers to those individuals who do not show cardiometabolic abnormalities. Our aim was to identify potential clinical and metabolic indicators that may help to distinguish between metabolically healthy and unhealthy individuals amongst overweight and obese children and adolescents. Methods: The study involved 246 overweight/obese and 212 normal-weight individuals enrolled in the LIFE Child study, aged between 6 and 18 years. Overweight/obese individuals without cardiovascular risk factors (fasting serum lipids, blood pressure, and glucose) were classified as MHO. Individuals meeting 1 or more criteria of cardiovascular risk factors were classified as metabolically unhealthy obesity (MUO). Results: Among the 246 overweight/obese individuals, 173 (70%) were MHO and 73 (30%) were MUO. The MHO individuals were younger, more likely to be male, and had lower BMI SDS. In the logistic regression models, uric acid (UA) SDS (OR 1.61, 95% CI 1.1–2.6, p = 0.004), waist circumference SDS (OR 2.50, 95% CI 1.2–6.4, p = 0.017), and C-peptide (OR 4.05, 95% CI 3.5–91, p = 0.003) were significant indicators of MUO. Conclusion: Our results suggest that nearly one-third of overweight/obese children are already identified as MUO. Serum levels of UA can be used as an indicator of unhealthy obesity in youth, where lower levels of UA indicate a lower risk and higher levels suggest a higher risk of MUO. We note that the relevance of identifying potential indicators remains the first most important step in future clinical research.

1.
Bussler
S
,
Penke
M
,
Flemming
G
,
Elhassan
YS
,
Kratzsch
J
,
Sergeyev
E
, et al
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence
.
Horm Res Paediatr
.
2017
;
88
(
3-4
):
181
93
.
[PubMed]
1663-2818
2.
Ng
M
,
Fleming
T
,
Robinson
M
,
Thomson
B
,
Graetz
N
,
Margono
C
, et al
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
.
Lancet
.
2014
Aug
;
384
(
9945
):
766
81
.
[PubMed]
0140-6736
3.
Ogden
CL
,
Carroll
MD
,
Kit
BK
,
Flegal
KM
.
Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010
.
JAMA
.
2012
Feb
;
307
(
5
):
483
90
.
[PubMed]
0098-7484
4.
Kiess
W
,
Penke
M
,
Sergeyev
E
,
Neef
M
,
Adler
M
,
Gausche
R
, et al
Childhood obesity at the crossroads
.
J Pediatr Endocrinol Metab
.
2015
May
;
28
(
5-6
):
481
4
.
[PubMed]
0334-018X
5.
Blüher
M
.
The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals
.
Curr Opin Lipidol
.
2010
Feb
;
21
(
1
):
38
43
.
[PubMed]
0957-9672
6.
Blüher
M
.
Are metabolically healthy obese individuals really healthy?
Eur J Endocrinol
.
2014
Dec
;
171
(
6
):
R209
19
.
[PubMed]
0804-4643
7.
Blüher
S
,
Schwarz
P
.
Metabolically healthy obesity from childhood to adulthood - Does weight status alone matter?
Metabolism
.
2014
Sep
;
63
(
9
):
1084
92
.
[PubMed]
0026-0495
8.
Prince
RL
,
Kuk
JL
,
Ambler
KA
,
Dhaliwal
J
,
Ball
GD
.
Predictors of metabolically healthy obesity in children
.
Diabetes Care
.
2014
May
;
37
(
5
):
1462
8
.
[PubMed]
0149-5992
9.
Rey-López
JP
,
de Rezende
LF
,
Pastor-Valero
M
,
Tess
BH
.
The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used
.
Obes Rev
.
2014
Oct
;
15
(
10
):
781
90
.
[PubMed]
1467-7881
10.
van Wijk
DF
,
Boekholdt
SM
,
Arsenault
BJ
,
Ahmadi-Abhari
S
,
Wareham
NJ
,
Stroes
ES
, et al
C-Reactive Protein Identifies Low-Risk Metabolically Healthy Obese Persons: The European Prospective Investigation of Cancer-Norfolk Prospective Population Study
.
J Am Heart Assoc
.
2016
Jun
;
5
(
6
):
e002823
.
[PubMed]
2047-9980
11.
Diniz, Maria de Fatima Haueisen Sander, Beleigoli AMR, Ribeiro ALP, Vidigal PG, Bensenor IM, Lotufo PA, et al. Factors associated with metabolically healthy status in obesity, overweight, and normal weight at baseline of ELSA-Brasil. Medicine (Baltimore).
2016
;95(27):e4010. doi: . PubMed PMID: 27755484.
12.
Gao
B
,
Zhang
L
,
Zhao
M
;
China National Survey of Chronic Kidney Disease Working Group Investigator
.
Underweight but metabolically abnormal phenotype: metabolic features and its association with cardiovascular disease
.
Eur J Intern Med
.
2016
Apr
;
29
:
46
51
.
[PubMed]
0953-6205
13.
Karelis
AD
,
Faraj
M
,
Bastard
JP
,
St-Pierre
DH
,
Brochu
M
,
Prud’homme
D
, et al
The metabolically healthy but obese individual presents a favorable inflammation profile
.
J Clin Endocrinol Metab
.
2005
Jul
;
90
(
7
):
4145
50
.
[PubMed]
0021-972X
14.
Liu
Z
,
Que
S
,
Zhou
L
,
Zheng
S
.
Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Meta-analysis of Prospective Studies
.
Sci Rep
.
2015
Sep
;
5
(
1
):
14325
.
[PubMed]
2045-2322
15.
Quante
M
,
Hesse
M
,
Döhnert
M
,
Fuchs
M
,
Hirsch
C
,
Sergeyev
E
, et al;
LIFE Child Study Investigators
.
The LIFE child study: a life course approach to disease and health
.
BMC Public Health
.
2012
Nov
;
12
(
1
):
1021
.
[PubMed]
1471-2458
16.
Poulain
T
,
Baber
R
,
Vogel
M
,
Pietzner
D
,
Kirsten
T
,
Jurkutat
A
, et al;
LIFE Child study team
.
The LIFE Child study: a population-based perinatal and pediatric cohort in Germany
.
Eur J Epidemiol
.
2017
Feb
;
32
(
2
):
145
58
.
[PubMed]
0393-2990
17.
Kromeyer-Hauschild
K
,
Wabitsch
M
,
Kunze
D
,
Geller
F
,
Geiß
HC
,
Hesse
V
, et al
Microsoft Word - 481_Pseudo-Postprint_mit Abb.doc: Perzentile für den Body-mass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben
.
Monatsschr Kinderheilkd
.
2001
;
149
(
8
):
807
18
. 0026-9298
18.
Reinehr
T
,
Holl
RW
,
Wabitsch
M
.
The German Working Group of Obesity in Childhood and Adolescence (AGA): improving the quality of care for overweight and obese children in Germany
.
Obes Facts
.
2008
;
1
(
1
):
26
32
.
[PubMed]
1662-4025
19.
Dathan-Stumpf
A
,
Vogel
M
,
Hiemisch
A
,
Thiery
J
,
Burkhardt
R
,
Kratzsch
J
, et al
Pediatric reference data of serum lipids and prevalence of dyslipidemia: results from a population-based cohort in Germany
.
Clin Biochem
.
2016
Jul
;
49
(
10-11
):
740
9
.
[PubMed]
0009-9120
20.
Tanner
JM
,
Whitehouse
RH
.
Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
.
Arch Dis Child
.
1976
Mar
;
51
(
3
):
170
9
.
[PubMed]
0003-9888
21.
Neuhauser
H
,
Thamm
M
.
Blutdruckmessung im Kinder- und Jugendgesundheitssurvey (KiGGS). Methodik und erste Ergebnisse
.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
.
2007
May-Jun
;
50
(
5-6
):
728
35
.
[PubMed]
1436-9990
22.
World Health Organisation
.
Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia.
2013
.
23.
Junge
J
,
Engel
C
,
Vogel
M
,
Naumann
S
,
Löffler
M
,
Thiery
J
, et al
Neck circumference is similarly predicting for impairment of glucose tolerance as classic anthropometric parameters among healthy and obese children and adolescents
.
J Pediatr Endocrinol Metab
.
2017
May
;
30
(
6
):
643
50
.
[PubMed]
0334-018X
24.
Matthews
DR
,
Hosker
JP
,
Rudenski
AS
,
Naylor
BA
,
Treacher
DF
,
Turner
RC
.
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
.
Diabetologia
.
1985
Jul
;
28
7
:
412
9
.
[PubMed]
0012-186X
25.
Matsuda
M
,
DeFronzo
RA
.
Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
.
Diabetes Care
.
1999
Sep
;
22
(
9
):
1462
70
.
[PubMed]
0149-5992
26.
Daniels
SR
,
Greer
FR
;
Committee on Nutrition
.
Lipid screening and cardiovascular health in childhood
.
Pediatrics
.
2008
Jul
;
122
(
1
):
198
208
.
[PubMed]
0031-4005
27.
Miersch
A
,
Vogel
M
,
Gausche
R
,
Siekmeyer
W
,
Pfäffle
R
,
Dittrich
K
, et al
Blood pressure tracking in children and adolescents
.
Pediatr Nephrol
.
2013
Dec
;
28
(
12
):
2351
9
.
[PubMed]
0931-041X
28.
Rigby
RA
,
Stasinopoulos
DM
.
Generalized additive models for location, scale and shape
.
J R Stat Soc C.
2005
;
54
(
3
):
507
54
.
29.
Core Team
. (
2014
) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria [cited 2017 Jun 29]. Available from: URL http://www.R-project.org/
30.
Vukovic
R
,
Milenkovic
T
,
Mitrovic
K
,
Todorovic
S
,
Plavsic
L
,
Vukovic
A
, et al
Preserved insulin sensitivity predicts metabolically healthy obese phenotype in children and adolescents
.
Eur J Pediatr
.
2015
Dec
;
174
(
12
):
1649
55
.
[PubMed]
0340-6199
31.
Chun
S
,
Lee
S
,
Son
HJ
,
Noh
HM
,
Oh
HY
,
Jang
HB
, et al
Clinical Characteristics and Metabolic Health Status of Obese Korean Children and Adolescents
.
Korean J Fam Med
.
2015
Sep
;
36
(
5
):
233
8
.
[PubMed]
2005-6443
32.
Smith
KJ
,
Bessell
E
,
Magnussen
CG
,
Dwyer
T
,
Venn
AJ
.
Does youth adiposity, or change in adiposity from youth to adulthood, predict metabolically healthy obesity in adulthood?
Pediatr Obes
.
2016
Oct
;
11
(
5
):
349
53
.
[PubMed]
2047-6302
33.
Hong
HC
,
Lee
JS
,
Choi
HY
,
Yang
SJ
,
Yoo
HJ
,
Seo
JA
, et al
Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey
.
Metabolism
.
2013
Sep
;
62
(
9
):
1305
12
.
[PubMed]
0026-0495
34.
Messier
V
,
Karelis
AD
,
Robillard
ME
,
Bellefeuille
P
,
Brochu
M
,
Lavoie
JM
, et al
Metabolically healthy but obese individuals: relationship with hepatic enzymes
.
Metabolism
.
2010
Jan
;
59
(
1
):
20
4
.
[PubMed]
0026-0495
35.
Khokhar
A
,
Chin
V
,
Perez-Colon
S
,
Farook
T
,
Bansal
S
,
Kochummen
E
, et al
Differences between Metabolically Healthy vs Unhealthy Obese Children and Adolescents
.
J Natl Med Assoc
.
2017
;
109
(
3
):
203
10
.
[PubMed]
0027-9684
36.
Weghuber
D
,
Zelzer
S
,
Stelzer
I
,
Paulmichl
K
,
Kammerhofer
D
,
Schnedl
W
, et al
High risk vs. “metabolically healthy” phenotype in juvenile obesity - neck subcutaneous adipose tissue and serum uric acid are clinically relevant
.
Exp Clin Endocrinol Diabetes
.
2013
Jul
;
121
(
7
):
384
90
.
[PubMed]
0947-7349
37.
Ding
WQ
,
Yan
YK
,
Zhang
MX
,
Cheng
H
,
Zhao
XY
,
Hou
DQ
, et al
Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents
.
J Hum Hypertens
.
2015
Sep
;
29
(
9
):
548
54
.
[PubMed]
0950-9240
38.
Reinehr
T
,
Wolters
B
,
Knop
C
,
Lass
N
,
Holl
RW
.
Strong effect of pubertal status on metabolic health in obese children: a longitudinal study
.
J Clin Endocrinol Metab
.
2015
Jan
;
100
(
1
):
301
8
.
[PubMed]
0021-972X
39.
Gómez-Ambrosi
J
,
Catalán
V
,
Rodríguez
A
,
Andrada
P
,
Ramírez
B
,
Ibáñez
P
, et al
Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy
.
Diabetes Care
.
2014
Oct
;
37
(
10
):
2813
21
.
[PubMed]
0149-5992
40.
Ahl
S
,
Guenther
M
,
Zhao
S
,
James
R
,
Marks
J
,
Szabo
A
, et al
Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals
.
J Clin Endocrinol Metab
.
2015
Nov
;
100
(
11
):
4172
80
.
[PubMed]
0021-972X
41.
Elmaogullari
S
,
Demirel
F
,
Hatipoglu
N
.
Risk factors that affect metabolic health status in obese children
.
J Pediatr Endocrinol Metab
.
2017
Jan
;
30
(
1
):
49
55
.
[PubMed]
0334-018X
42.
Abdullah
A
,
Hasan
H
,
Raigangar
V
,
Bani-Issa
W
.
C-Peptide versus insulin: relationships with risk biomarkers of cardiovascular disease in metabolic syndrome in young arab females
.
Int J Endocrinol
.
2012
;
2012
:
420792
.
[PubMed]
1687-8337
43.
Ciresi
A
,
Cicciò
F
,
Radellini
S
,
Giordano
C
.
Utility of C-peptide for a reliable estimate of insulin secretion in children with growth hormone deficiency
.
Growth Horm IGF Res
.
2016
Aug
;
29
:
71
7
.
[PubMed]
1096-6374
44.
Cardellini
M
,
Farcomeni
A
,
Ballanti
M
,
Morelli
M
,
Davato
F
,
Cardolini
I
, et al
C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease
.
Diab Vasc Dis Res
.
2017
Sep
;
14
(
5
):
395
9
.
[PubMed]
1479-1641
45.
Mangge
H
,
Zelzer
S
,
Puerstner
P
,
Schnedl
WJ
,
Reeves
G
,
Postolache
TT
, et al
Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults
.
Obesity (Silver Spring)
.
2013
Jan
;
21
(
1
):
E71
7
.
[PubMed]
1930-7381
46.
Harlan
WR
,
Cornoni-Huntley
J
,
Leaverton
PE
.
Physiologic determinants of serum urate levels in adolescence
.
Pediatrics
.
1979
Apr
;
63
(
4
):
569
75
.
[PubMed]
0031-4005
47.
Gustafsson
D
,
Unwin
R
.
The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality
.
BMC Nephrol
.
2013
Jul
;
14
(
1
):
164
.
[PubMed]
1471-2369
48.
Choi
HK
,
Ford
ES
.
Prevalence of the metabolic syndrome in individuals with hyperuricemia
.
Am J Med
.
2007
May
;
120
(
5
):
442
7
.
[PubMed]
0002-9343
49.
Harada
M
,
Izawa
A
,
Hidaka
H
,
Nakanishi
K
,
Terasawa
F
,
Motoki
H
, et al;
Study Project on Prevention of Metabolic Syndrome among Children, Adolescents, and Young Adults in Shinshu
.
Importance of cystatin C and uric acid levels in the association of cardiometabolic risk factors in Japanese junior high school students
.
J Cardiol
.
2017
Jan
;
69
(
1
):
222
7
.
[PubMed]
0914-5087
50.
Hayashino
Y
,
Okamura
S
,
Tsujii
S
,
Ishii
H
.
Association of serum uric acid levels with the risk of development or progression of albuminuria among Japanese patients with type 2 diabetes: a prospective cohort study [Diabetes Distress and Care Registry at Tenri (DDCRT 10)]
.
Acta Diabetol
.
2016
Aug
;
53
(
4
):
599
607
.
[PubMed]
0940-5429
51.
Kiess
W
,
Hoppmann
J
,
Gesing
J
,
Penke
M
,
Körner
A
,
Kratzsch
J
, et al
Puberty - genes, environment and clinical issues
.
J Pediatr Endocrinol Metab
.
2016
Nov
;
29
(
11
):
1229
31
.
[PubMed]
2191-0251
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.